Latest News - Pfizer
Top Corporates Hub
Pfizer
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
08.10.2025 14:15
These biotechs could finally come into their own by the end of the decade.
Pfizer: Mastering The Art Of The Deal With Metsera - Upgraded To Buy
08.10.2025 12:18
Pfizer has re-entered the obesity drug sector by acquiring Metsera, Inc., having successfully outmaneuvered six other bidders. Click to read why PFE is a Buy.
Mikael Dolsten, M.D., Ph.D., Joins TRIO Pharmaceuticals as Chairman
08.10.2025 11:00
SAN CARLOS, Calif., October 08, 2025--Mikael Dolsten, M.D., Ph.D., Joins TRIO Pharmaceuticals as Chairman
Pfizer Offers High Yield And Capital Appreciation Opportunities (Technical Analysis)
07.10.2025 01:16
Pfizer surged 15% last week on positive news, including a direct-to-consumer deal and a three-year tariff reprieve. Read why PFE stock is a Buy.
Pfizer Offers High Yield And Capital Appreciation Opportunities (Technical Analysis)
07.10.2025 01:16
Pfizer surged 15% last week on positive news, including a direct-to-consumer deal and a three-year tariff reprieve. Read why PFE stock is a Buy.
Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know
06.10.2025 17:57
LLY shares have jumped 16% last week as Pfizer's landmark government deal boosted investor confidence across the pharma sector.
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
06.10.2025 16:10
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Luckie Names Scott Gelber Chief Executive Officer to Lead Next Phase of Agency's Growth
06.10.2025 13:56
Marketing agency Luckie announced today that Scott Gelber is the company's new Chief Executive Officer, marking a key leadership transition as the firm looks to accelerate growth across the Southeast.
Trump says the US has secured $17 trillion in new investments. The real number is likely much less
06.10.2025 13:00
The White House website lists total investments at $8.8 trillion, though that figure appears to be padded with some investment commitments made during Joe Biden's presidency. The White House didn't lay out the math after multiple requests as to how Trump calculated $17 trillion in investment commitments.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
06.10.2025 13:00
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
06.10.2025 13:00
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Pfizer (PFE): Exploring Valuation Opportunity After Recent 15% Share Price Uptick
06.10.2025 11:27
Pfizer (PFE) has seen its stock price move gradually higher over the past week, rising nearly 15% in that period. Investors seem interested in the company’s recent performance and underlying fundamentals, given these moderate gains. See our latest analysis for Pfizer. Pfizer's latest rally adds to a period of modest but steady momentum, building on its 1-year total shareholder return of just 0.3%. While the company’s share price has edged up recently, the bigger story is how sentiment could...
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio
06.10.2025 10:57
Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.
3 Reasons to Buy Pfizer Stock Now
06.10.2025 08:59
After years of underperformance, the future is looking brighter for the drugmaker.
Pfizer: TrumpRx Unlocks Opportunities With Drug Discounts
06.10.2025 08:00
Pfizer delivered strong 2Q25 results with double-digit revenue growth and margin expansion. Click here to read why PFE stock is a Buy.
Trump administration could lower drug prices by making other nations pay more
06.10.2025 07:32
The Trump administration often touts its efforts to lower prices in the U.S. by matching what other countries pay, but there’s more to this policy story.
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy?
03.10.2025 07:15
The pharma giant just eliminated two big risks.
Pfizer’s Drug-Price Deal With Trump Followed Months of Deadlock
03.10.2025 02:11
The post, however, played a critical role in cementing a deal with one of the world’s largest pharmaceutical companies, Pfizer Inc., according to senior officials from the White House and the Centers for Medicare and Medicaid Services who requested anonymity to discuss the inner workings of the process. For months, Pfizer and the White House had been deadlocked in their negotiations over how to address one of President Trump’s most critical issues: lowering US drug prices.
Inside Pfizer’s Drug-Pricing Deal With the Trump Administration
03.10.2025 01:46
Down-to-the wire team negotiations capped a long dance between President Trump and CEO Albert Bourla.
3 Things You Need to Know if You Buy Pfizer Today
02.10.2025 11:02
Pfizer has an attractive 7.2% dividend yield, but there are some pros and cons you need to understand before you buy it.